...
首页> 外文期刊>Journal of Medicinal Chemistry >Synthesis and structure-activity relationships of carboxyflavones as structurally rigid CysLT1 (LTD4) receptor antagonists.
【24h】

Synthesis and structure-activity relationships of carboxyflavones as structurally rigid CysLT1 (LTD4) receptor antagonists.

机译:羧基黄酮作为结构刚性的CysLT1(LTD4)受体拮抗剂的合成及其构效关系。

获取原文
获取原文并翻译 | 示例

摘要

The synthesis and CysLT1 receptor affinities of a new series of highly rigid 3'- and 4'-(2-quinolinylmethoxy)- or 3'- and 4'-[2-(2-quinolinyl)ethenyl]-substituted, 6-, 7-, or 8-carboxylated flavones are described. CysLT1 receptor affinities of the flavones (down to 11 nM) were determined by their ability to displace [3H]LTD4 from its receptor in guinea pig lung membranes. Structure-affinity relationship studies showed that the relative positions of the carboxylic acid and the quinoline moiety were critical for CysLT1 affinities. While the carboxyl is optimal in the 8 position but tolerated in the 6 position, only the 6- and not the 8-tetrazole has significant activity. The quinoline moiety may be connected to the flavone skeleton by an ethenyl or a methoxy linker, but the substitution position is important for high affinity, especially in the 6-carboxylated flavones. 4'-Substituted 6-carboxyflavones are essentially inactive, whereas the 3'-substituted analogues have submicromolar CysLT1 affinity. Replacement of the quinoline by other heteroaromates generally leads to decreased affinities, with the phenyl and naphthyl analogues displaying only little or no affinity, while the 7-chloroquinoline analogue is comparable in activity to the quinoline. Flavones having CysLT1 receptor affinities of 10-30 nM were selected for determination of their inhibitory effects on the LTD4-induced contraction of guinea pig ileum in vitro. The IC50 values ranged between 15 and 100 nM. Compound 5d (8-carboxy-6-chloro-3'-(2-quinolinylmethoxy)flavone, VUF 5087) was selected for further research because of its high potency in the functional assay. This series contains the most rigid CysLT1 receptor antagonists known to date, and they are useful in the development of a CysLT1 antagonist model, which is discussed in the companion paper.
机译:一系列新的高度刚性的3'-和4'-(2-喹啉基甲氧基)-或3'-和4'-[2-(2-喹啉基)乙烯基]取代的6'-的合成和CysLT1受体亲和力描述了7-或8-羧基黄酮。黄酮的CysLT1受体亲和力(低至11 nM)取决于它们在豚鼠肺膜中从其受体中置换[3H] LTD4的能力。结构亲和关系研究表明,羧酸和喹啉部分的相对位置对于CysLT1亲和力至关重要。尽管羧基在8位上是最佳的,但在6位上是可容忍的,但只有6-而不是8-四唑具有明显的活性。喹啉部分可以通过乙烯基或甲氧基连接基与黄酮骨架相连,但是取代位置对于高亲和力是重要的,尤其是在6-羧化黄酮中。 4'-取代的6-羧基黄酮基本上没有活性,而3'-取代的类似物具有亚微摩尔的CysLT1亲和力。喹啉被其他杂芳族酸酯取代通常会导致亲和力下降,苯基和萘基类似物仅表现出很少或没有亲和力,而7-氯喹啉类似物的活性与喹啉相当。选择具有CysLT1受体亲和力为10-30 nM的黄酮,以测定其对LTD4诱导的豚鼠回肠收缩的抑制作用。 IC50值在15到100 nM之间。选择化合物5d(8-羧基-6-氯3'-(2-喹啉基甲氧基)黄酮,VUF 5087)是因为其在功能测定中的高功效而被进一步研究。该系列包含迄今为止已知的最严格的CysLT1受体拮抗剂,它们可用于开发CysLT1拮抗剂模型,该模型将在随附的论文中进行讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号